The JHM strain of mouse hepatitis virus induces a spike protein-specific Derestricted cytotoxic T cell response

Journal of General Virology

Volumn 77, Issue 2, 1996, Pages 315-325

  Bergmann, Cornelia C ^a   Yao, Qin ^a   Lin, Mark ^a   Stohlman, Stephen A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUTANT PROTEIN; STRUCTURAL PROTEIN; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE ACTIVATION; TARGET CELL; VACCINIA VIRUS; VIRUS IMMUNITY; VIRUS NUCLEOCAPSID; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; EPITOPE MAPPING; H-2 ANTIGENS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MURINE HEPATITIS VIRUS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL ENVELOPE PROTEINS;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS; MURINE HEPATITIS VIRUS STRAIN 4; VACCINIA; VACCINIA VIRUS;

EID: 0030025203     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-2-315     Document Type: Article

References (53)

1. d restricted CTL cpitope in the mouse hepatitis virus nudeocapsid protein. Journal of Virology 67, 7041-7049.
2. BERGMANN, C., STOHLMAN, S. A. & MCMILLAN, M. (1993b). An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein European Journal of Immunology 23, 2777-2781.
3. BUCHMEIER, M. J., LEWICKI, H. A., TALBOT, P. J & KNOBLER, R. L. (1984). Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132, 261-270
4. CASTELMUR, I., DIPAOLO, C., BACHMANN, M. F., HENGARTNER, H., ZINKERNAGEL, R. M. & KUNDIG, T. M. (1993). Comparison of the sensitivity of in vivo and in vitro assays for detection of antiviral cytotoxic T cell activity. Cellular Immunology 151, 460-466.
5. + CTL epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. Journal of Virology 69, 8127-8131.
6. CASTRO, R. F., EVANS, G. D., JASZEWSKI, A. & PERLMAN, S. (1994). Coronavirus-induced demyelination occurs in the presence of virus-specific cytotoxic T cells. Virology 200, 733-743.
7. CEREDIG, R., LOWENTHAL, J. W., NABHOLZ, M. & MACDONALD, H. R. (1985). Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 314, 98-100.
8. DORRIES, R., SCHWENDER, S., IMRICH, H. & HARMS, H. (1991). Population dynamics of lymphocyte subsets in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology 74, 539-545.
9. ELROY-STEIN, O., FUERST, T. R. & Moss, B. (1989). Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proceedings of the National Academy of Sciences, USA 86, 6126-6130.
10. FAZAKERLEY, J. K. & BUCHMEIER, M. J. (1993). Pathogenesis of virus-induced demyelination. Advances in Virus Research 42, 249-324.
11. FLEMING, J. O., TROUSDALE, M , EL-ZAATARI, F., STOHLMAN, S. A. & WEINER, L P. (1986). Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. Journal of Virology 58, 869-875.
12. FLEMING, J. O., TROUSDALE, M D., BRADBURY, J., STOHLMAN, S. A. & WEINER, L. P. (1987). Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease. Microbial Pathogenesis 3, 9-20.
13. FLEMING, J. O., SHUBIN, R. A , SUSSMAN, M. A., CASTEEL, N. & STOHLMAN, S. A. (1988). Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Viroiogy 168, 162-167.
14. GALLAGHER, T. M., PARKER. S. E & BUCHMEIER, M. (1990). Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. Journal of Virology 64, 731-741.
15. GOMBOLD, J. L. & WEISS, S. R. (1992). Mouse hepatitis virus A59 increases steady-state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system. Microbial Pathogenesis 13, 493-505.
16. + T cells. Microbial Pathogenesis 18, 211-222.
17. + cytotoxic T cells against mouse hepatitis virus A59. Immunology 84, 521-527.
18. HILTON, A., MIZZEN, L., MACINTYRE, G., CHELEY, S. & ANDERSON, R. (1986) Translational control in murine hepatitis virus infection. Journal of General Virology 67, 923-932.
19. KERSTING, G. & PETTE, E. (1956). Zur pathohistologie und pathogenese der experimentellen JHM-virusencephalomyelitis des affen. Deutsche Zeitschrift fuer Nervenheilkunde 174, 283-304.
20. + T cells. Journal of Immunology 147, 2317-2323.
21. KYUWA, S. & STOHLMAN, S. A. (1990). Pathogenesis of a neurotropic murine coronavirus strain JHM in the central nervous system. Seminars in Virology 1, 273-280.
22. KYUWA, S., YAMAGUCHI, K., TOYODA, Y & FUJIWARA, K. (1991). Induction of self-reactive T cells after murine coronavirus infection. Journal of Virology 65, 1789-1795.
23. KYUWA, S., COHEN, M , NELSON, G., TAMARA, S. M. & STOHLMAN, S. A. (1994). Modulation of cellular macromolecular synthesis by coronavirus: implication for pathogenesis. Journal of Virology 68, 6815-6819.
24. LA MONICA, N., BANNER, L. R. MORRIS, V L. & LAI, M. M. C. (1991). Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM. Virology 182, 883-888.
25. LAVI, E., GILDEN, D. H., WROBLEWSKA, Z., RORKE, L. B. & WEISS, S. R. (1984). Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34, 597-603.
26. LECOMTE, J., CAINELLI-GEBARA, U., MERCIER, G., MANSOUR, S., TALBOT, P., LAESIER, G. & OTH, D (1987). Protection from mouse hepatitis virus type 3-induced acute disease by anti-nucleoprotein monoclonal antibody. Archives of Virology 97, 123-130.
27. LUYTJES, W., STURMAN, L. S., BREDENBEEK, P. J., CHARITE, J., VAN DER ZEUST, B. A. M., HORZINEK, M. C. & SPAAN, W. J. M. (1987). Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology 161, 479-487.
28. MORRIS, V. L., TIESZER, C., MACKINNON, J. & PERCY, D. (1989). Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease. Virology 169, 127-136.
29. MURRAY, R. S., CAI, G.-Y., HOEL, K., ZHANG, J.-Y., SOIKE, K. F. & CABIRAC, G. F. (1992a). Coronavirus infects and causes demyelination in primate central nervous system. Virology 188, 274-284.
30. MURRAY, R. S., BROWN, B., BRIAN, D. & CABIRAC, G. F. (1992b). Detection of coronavirus RNA and antigen in multiple sclerosis brain. Annals of Neurology 31, 525-533.
31. NAKANAGA, K., YAMANOUCHI, K. & FUJIWARA, K. (1986). Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. Journal of Virology 59, 168-171.
32. PARKER, S. E., GALLAGHER, T. M. & BUCHMEIER, M. J. (1989). Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 173, 664-673.
33. RAMMENSEE, H.-G., FALK, K. & ROTZSCHKE, O. (1993). Peptides naturally presented by MHC class I molecules. Annual Review of Immunology 11, 213-244.
34. SARIMENTO, M., GLASEBROOK, A. L. & FITCH, F. (1980). IgG and IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt2 antigen block T cell-mediated cytolysis in the absence of complement. Journal of Immunology 125, 2665-2672.
35. SCHMIDT, I., SKINNER. M. & SIDDELL, S. (1987) Nucleotide sequence of the gene encoding the surface projection glycoprotein of coronavirus MHV-JHM. Journal of General Virology 68, 47-56
36. STEWARD, J. N., MOURNIR, S. & TALBOT, P. J. (1992). Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 91, 502-505
37. STOHLMAN, S. A., BRATON, P. R., FLEMING, J. O., WEINER, L. P. & LAI, M. M. C. (1982). Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. Journal of General Virology 63, 265-275.
38. STOHLMAN, S. A., MATSUSHIMA, G. K., CASTEEL, N. & WEINER, L. P. (1986). In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication 1. Journal of Immunology 136, 3052-3056.
39. STOHLMAN, S. A., SUSSMAN, M. A., MATSUSHIMA, G. K., SHUBIN, R. A. & ERLICH, S. S. (1988). Delayed-type hypersensitivity response in the central nervous system during JHM virus infection requires viral specificity for protection. Journal of Neuroimmunology 19, 255-268.
40. d restricted and specific for the carboxy terminus. Virology 189, 217-224.
41. STOHLMAN, S. A., KYUWA, S., POLO, J., BRADY, D., LAI, M. M C. & BERGMANN, C. C. (1993). Characterization of mouse hepatitis virus specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. Journal of Virology 67, 7050-7059.
42. STOHLMAN, S. A., HINTON, D. R., CUA, D., DIMACALI, E , SENSINTAFFAR, J., HOFMAN, F. M., TAHARA, S. M. & YAO, Q. (1995a). Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis. Journal of Virology 69, 5898-5903
43. STOHLMAN, S. A., BERGMANN, C. C , VAN DER VEEN, R. C. & HINTON, D. (19956). Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. Journal of Virology 69, 684-694.
44. SUSSMAN, M. A., SHUBIN, R. A., KYUWA, S. & STOHLMAN, S. A (1989). T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. Journal of Virology 63, 3051-3056.
45. SUZUMURA, A., LAVI, E., WEISS, S R. & SILBERBERG, D. H (1986). Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science 232, 991-993.
46. TAHARA, S., DIETLIN, T., BERGMANN, C., NELSON, G., KYUWA, S. & STOHLMAN, S. (1994). Translational regulation in coronavirus: effect on mRNA efficiency. Virology 202, 621-630.
47. WANG, F. I., FLEMING, J. O. & LAI, M. M. C. (1992). Sequence analysis of the spike protein gene of murine coronavirus variants : study of genetic sites affecting neuropathogenicity. Virology 186, 742-749.
48. + T cells. Journal of Virology 64, 4589-4592.
49. WILLIAMSON, J. B. P., SYKES, K. & STOHLMAN, S. A. (1991). Characterization of brain infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. Journal of Neuroimmunology 32, 199-207.
50. WYSOCKA, M., KORNGOLD, R., YEWDELL, J. & BENNINK, J. (1989) Target and effector cell fusion accounts for B lymphocyte-mediated lysis of mouse hepatitis virus-infected cells. Journal of General Virology 70, 1465-1472.
51. YAMAGUCHI, K., GOTO, N., KYUWA, S., HAYAMI, M. & TOYODA, Y. (1991). Protection of mice from a lethal coronavirus infection in the central nervous system adoptive transfer of virus-specific T cell clones. Journal of Neuroimmunology 32, 1-9
52. YOKOMORI, K., BAKER, S., STOHLMAN, S. A. & LAI, M. M. C. (1992) Hemagglutinin esterase specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. Journal of Virology 66, 2865-2874.
53. Yu, Z., BI, W., WEISS, S. R. & LEIBOWITZ, J. L. (1994). Mouse hepatitis virus gene 5b protein is a new virion envelope protein Virology 202, 1018-1023.